Ithos Global is performing regulatory assessments for a cosmetics company.
They want to present Cosmetic products into Japan that have substances currently being regulated as though they were being used inside of Quasi Drugs.
They don't want to make product label claims that are consistent with what is needed for Quasi Drugs, and they want to present these products as plain cosmetic products.
So the question is: can they include these substances and register them as Cosmetic products, without bumping the entire product up to Quasi Drug status....
We are looking for answers on this for Japan and are hoping for a quick turn around if this is possible.